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Background: Quinolinic acid (QA) is a neurotoxin and has been shown to be
present at high levels in the central nervous system of patients with certain
diseases, such as AIDS and meningitis. The enzyme quinolinic acid phosphoribo-
syltransferase (QAPRTase) provides the only route for QA metabolism and is
also an essential step in de novo NAD biosynthesis. QAPRTase catalyzes the
synthesis of nicotinic acid mononucleotide (NAMN) from QA and 5-phosphoribo-
syl-1-pyrophosphate (PRPP). The structures of several phosphoribosyltrans-
ferases (PRTases) have been reported, and all have shown a similar fold of a
five-stranded b sheet surrounded by four a helices. A  conserved sequence motif
of 13 residues is common to these ‘type I’ PRTases but is not observed in the
QAPRTase sequence, suggestive of a different fold for this enzyme.
Results: The crystal structure of QAPRTase from Salmonella typhimurium has
been determined with bound QA to 2.8 Å resolution, and with bound NAMN to
3.0 Å resolution. Most significantly, the enzyme shows a completely novel fold for
a PRTase enzyme comprising a two-domain structure: a mixed a/b N-terminal
domain and an a/b barrel-like domain containing seven b strands. The active site
is located at the C-terminal ends of the b strands of the a/b barrel, and is
bordered by the N-terminal domain of the second subunit of the dimer. The
active site is largely composed of a number of conserved charged residues that
appear to be important for substrate binding and catalysis. 
Conclusions: The seven-stranded a/b-barrel domain of QAPRTase is very similar
in structure to the eight-stranded a/b-barrel enzymes. The structure shows a
phosphate-binding site that appears to be conserved among many a/b-barrel
enzymes including indole-3-glycerol phosphate synthase and flavocytochrome b2.
The new fold observed here demonstrates that the PRTase enzymes have evolved
their similar chemistry from at least two completely different protein architectures.
Introduction
Quinolinic acid phosphoribosyltransferase (QAPRTase;
EC 2.4.2.19) is required for the de novo biosynthesis of
NAD in both prokaryotes and eukaryotes [1]. The enzyme
catalyzes the reaction between quinolinic acid (QA) and
5-phosphoribosyl-1-pyrophosphate (PRPP), to yield nico-
tinic acid mononucleotide (NAMN), pyrophosphate and
CO2, the latter resulting from decarboxylation at position
2 of the quinolinate ring (Fig. 1). QA is the first intermedi-
ate in de novo NAD synthesis that is common to all organ-
isms, being produced via the degradation of tryptophan in
most eukaryotes, and from dihydroxyacetone phosphate
and L-aspartate in prokaryotes [1,2]. In addition to the de
novo synthesis of NAD, salvage pathways exist (the purine
nucleotide cycles or pncs) that allow recycling of NAD,
usually via degradation of NAD in several steps to nico-
tinic acid (NA), followed by conversion of NA by nicotinic
acid phosphoribosyltransferase (NAPRTase) to NAMN.
In Salmonella typhimurium and Escherichia coli, neither
QAPRTase nor NAPRTase can utilize the related sub-
strate (NA or QA, respectively) at sufficient rates to
sustain growth, pointing to high substrate specificity [3–5].
A lack of significant levels of NAPRTase activity in strains
of Mycobacterium tuberculosis results in the secretion of NA,
as NAD cannot be recycled, although the NAD degrada-
tion enzymes remain very active [1]. Thus, the de novo
pathway of NAD biosynthesis may be a possible target for
drug design against this organism.
QAPRTase has been grouped with nine other enzymes,
(phosphoribosyltransferases, PRTases) that catalyze chem-
ically similar phosphoribosyl transfer reactions using the
substrate PRPP [6]. The PRTases are involved in de novo
and salvage reactions of nucleotide synthesis, as well as in
histidine and tryptophan biosynthesis. To date, crystal
structures have been determined for several PRTase
enzymes and all show a common ‘PRTase fold’ (the ‘type
I’ fold) composed of a central parallel b sheet, of five
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b strands, surrounded by a helices. The fold contains a
common recognition motif of thirteen residues which is
critical for PRPP binding and catalysis [7–11]. Typically,
this 13-residue motif consists of four hydrophobic residues,
followed by two acidic residues (usually aspartic acid),
then two more hydrophobic residues and four smaller
residues, including at least one glycine. The first four
hydrophobic residues form the central b strand of the five-
stranded b sheet. The two acidic sidechains lie in close
proximity to the ribose group of the substrate and appear
to be involved in the stabilization of a positively charged
transition state [7,9]. The mechanism of nucleotide forma-
tion in hypoxanthine guanine PRTase (HGPRTase) and
orotate PRTase has been proposed to proceed via a transi-
tion state which has oxocarbonium character at the ribose
C1′–O4′ [12]. The four small residues at the end of the
conserved motif serve to bind the 5′-phosphate of the
PRPP and nucleotide.
Not all enzymes with PRTase activity show a convincing
sequence corresponding to a type I PRPP-binding motif. In
particular, QAPRTase [13], NAPRTase [14] and adenosine
triphosphate PRTase do not appear to contain an obvious
13-residue motif. It is also surprising that QAPRTase shows
little or no sequence similarity to NAPRTase, despite the
almost identical reaction catalyzed by these two enzymes
[13]. As these enzymes lack the type I PRPP-binding motif,
it becomes possible that there might be at least two differ-
ent types of PRTase fold. It is of interest to observe how a
basically similar catalytic reaction can be undertaken by a
different protein architecture, and specifically what motifs
replace the dicarboxylate pair and phosphate-binding loop
of the type I PRTase fold. In this paper, we present the
three-dimensional (3D) structure of QAPRTase, which
shows a new fold for a member of the PRTase group of
enzymes. The active site and the residues likely to be
involved in substrate binding and catalysis have also been
identified.
Results and discussion
Overall fold of QAPRTase
A ribbon diagram of S. typhimurium QAPRTase is shown in
Figure 2a, with a stereo diagram of the Ca trace shown in
Figure 2b. The enzyme consists of two domains: an N-
terminal openface sandwich domain comprising residues
8–135, and a C-terminal a/b barrel domain (residues
135–280). The C-terminal b strand (residues 284–296)
forms a b sheet with the N-terminal domain b strand B1.
The most striking and unexpected feature of the protein is
the a/b barrel structure, which differs significantly from
conventional eight-stranded a/b barrels, in following an
abab(ba)4b rather than (ba)8 topology.
The N-terminal domain is an antiparallel b openface sand-
wich structure comprised of a four-stranded b sheet
stacked with four a helices. The bottom layer of the ‘sand-
wich’ is the four-stranded antiparallel b sheet consisting of
b strands B1, B2, B3 and the end of the C-terminal
b strand (B11; residues 285 to 296). Helices A2, A3 and A4
form the second layer of the sandwich. Typically, openface
sandwich structures have been described as two-layer
structures [15], but strictly the N-terminal domain of
QAPRTase is a three layer sandwich, as the N-terminal
long a helix (A1) stacks on top of helices A3 and A4.
Strands B1 and B2 have short continuation b strands (B1a
and B2a) located after a sharp bend, forming a short
antiparallel two-stranded b sheet. The N-terminal domain
ends with another long a helix, A4, which also marks the
start of the a/b barrel.
The seven b strands of the a/b barrel are flanked by the
C-terminal end of helix A4, and by only five additional
helices. The resulting structure shows a large ‘gap’
between the second and third strands of the a/b barrel
(strands B5 and B6), where there would be an additional
b strand and two a helices in a normal (ba)8 structure.
There is an additional short helix (A6a) between the ba
unit of strand B6 and helix A6. Finally, instead of a final
a helix after the last b strand of the barrel, strand B10
leads into a short a helix (A10) of 3–4 residues, then con-
tinues as the C-terminal b strand (B11; residues 285–296).
The QAPRTase a/b barrel
The QAPRTase a/b barrel is unlike any other a/b barrel
structure reported to date. Although a seven b-stranded
a/b barrel has been previously reported in the structure 
of cellobiohydrolase II (CBHII) [16], this differs in topol-
ogy from QAPRTase. In CBHII, the gap between b
strands occurs between the first and last strands of the
barrel, whereas in QAPRTase, it occurs between the
second (B5) and third (B6) b strands. In important
respects, the QAPRTase barrel is like a conventional ba8
structure (and CBHII), having the same overall appear-
ance, shear number (8) [17] and tilt angle (~35°) for the
b strands. The absent b strand leaves a gap rather than
compressing to an evenly spaced seven b-stranded barrel.
There are no hydrogen bonds between strands B5 and B6,
and these two strands lie nearly orthogonal to each other.
The hydrogen bonding between strands B4 and B5, on
48 Structure 1997, Vol 5 No 1
Figure 1
The reaction scheme of QAPRTase.
one side of the gap is weaker than between the other
strands; only one hydrogen bond is formed between these
two b strands.
The a/b barrel of QAPRTase has an almost circular cross-
section, like the a/b barrel of indole-3-glycerol phosphate
synthase (IGPS; a subunit of the bifunctional enzyme N-5′-
phosphoribosylanthranilate isomerase/IGPS) [18], and not
as eliptical as triose phosphate isomerase [19]. Using the
DALI algorithm for 3D structure comparisons [20], the
highest scoring similar structures were: IGPS, N-acetylneu-
raminate lyase [21], the a subunit of tryptophan synthase,
TRPS(a) [22], and flavocytochrome b2 [23], all of which
have (ba)8 structures (Table 1). There does not seem to be
any unifying functional relationship between QAPRTase
and any of these structures, and thus the similarity is not
likely to be of any particular significance to the reaction
chemistry. However, it is interesting that several of the top
scorers listed in Table 1 are enzymes that bind phosphate
groups (see below).
Description of the dimer
S. typhimurium QAPRTase has been shown to exist as a
dimer in solution [13]. A dimer was also observed in the
asymmetric unit of the crystal (Fig. 3). The subunits are
related by a non-crystallographic twofold axis (k=179°).
The structure indicates that a dimer is essential for full
activity of S. typhimurium QAPRTase, as the two subunits
both contribute to the active site (see full description
below). The two subunits are very similar, with a root
mean square (rms) deviation of Ca atoms of 0.74Å (for 
the QAPRTase–NAMN structure, the rms deviation is
0.56Å). When the subunits are overlaid in the N-terminal
domain, the region encompassing residues 180–206 of the
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Figure 2
The overall fold of the QAPRTase monomer.
(a) Ribbon diagram of the QAPRTase
monomer. Secondary structure elements are
sequentially labeled; helices are shown in
magenta, b strands in yellow and loops in
blue. (Figure prepared using SETOR [48].)
(b) Stereo diagram of the Ca trace of the
QAPRTase monomer; the positions of every
twentieth residue are marked with a filled
circle at the Ca position and are numbered.
(Figure prepared using Molscript [49].)
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a/b barrel deviates by 2–3Å between the non-crystallo-
graphic symmetry (NCS) related subunits (i.e. there is a
shift of this segment of the a/b barrel). If residues 180–206
are omitted from the superposition, the rms deviation is
only 0.54Å for Ca atoms (0.32Å for the QAPRTase–
NAMN structure). Dimerization buries about 24%
(2860Å2) of the surface area of each subunit. The dimer
interface is fairly evenly distributed between charged or
polar residues and hydrophobic residues. 
Residues at the end of a helix A1, the following loop
(residues 17–42), a helix A2, residues 154–157, residues
176–191 (containing B6 and A6a) and 284–288 (B11) are all
involved in interactions at the dimer interface. There are a
total of six hydrogen bonds at the dimer interface (Fig. 3).
Two hydrogen bonds are formed between b strand B11
and its NCS mate, between the mainchain atoms of Val286
and its equivalent residue. Other hydrogen bonds are
formed between sidechains Arg152 and Asp33, between
the sidechain of Arg159 and the mainchain of Glu32, and
between mainchain atoms in residues Asp33 and Leu178.
Description of the active site: QA binding
The QA molecule is located near the center of the
a/b barrel, close to the C-terminal end of b strand B4.
QAPRTase is similar to other a/b barrel enzymes in the
location of the active site at the C-terminal ends of the
b strands [24]. The active site is also bordered by the N-
terminal domain of the other molecule of the dimer
(Fig. 3), which limits the solvent access to the QA (only
36Å2 of 151Å2 of the van der Waals surface of QA is
exposed). At the resolution of the data, it was difficult to
unambiguously orient the QA molecule. The orientation 
of QA shown in Figure 4 was deduced to be the most
likely, based on the interactions with the protein and the
appearance of ‘omit’ electron-density maps (Fig. 5). The
3-carboxylate group of QA is within hydrogen-bonding
distance of the sidechain atoms Nε and Nh of Arg175 and
Nε of Arg152, whereas the 2-carboxylate group only
appears to hydrogen bond to the mainchain NH of Arg152.
The 2-carboxylate group is ~4 Å from the sidechains of
Lys153 and Arg118 (the latter residue from the N-terminal
domain of the other molecule of the dimer). His174 is
placed near C5 of the quinolinate ring and is also ~4 Å from
the C3 carboxylate group. These sidechains create a basic
pocket for the binding of the anionic substrate (Fig. 6).
Leu183 and Thr151 are within van der Waals distance of
the pyridine ring.
There are several differences in the active-site geometries
in the two molecules of the QAPRTase dimer. In mol-
ecule A, Lys153 is 3.8Å from the C2 carboxylate of QA,
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Table 1
Top nine matches of 3D structures with the a/b barrel of
QAPRTase.*
Z score† Rmsd (Å)†† LALI‡ Identity (%)§ Protein
8.8 3.4 137 15 Indole-3-glycerol 
phosphate synthase
7.9 3.7 139 9 N-Acetylneuraminate 
lyase
7.4 6.3 151 7 Flavocytochrome b2
7.1 3.5 137 15 TRPS(a)
6.4 3.4 92 8 Succinyl-CoA 
synthetase
6.3 3.5 134 6 Concanavalin B
5.4 3.6 138 8 b-Amylase
5.4 3.2 131 10 1,4-a-D-Glucan 
maltotetrahydrolase
5.3 4.0 136 11 Xylanase A 
catalytic core
*The DALI algorithm [20] was used to make the structural
comparisons. †The Z score is the strength of structural similarity in
standard deviations above expected. ††Positional root mean square
deviation of equivalenced positions. ‡Length of entire chain of
equivalenced structure. §Sequence identity of equivalent positions.
Figure 3
Two representations of the dimer of QAPRTase. (a,b) The two views
are approximately orthogonal to one another. The figures show the
backbone ribbon of QAPRTase and stick models of NAMN bound at
the active sites. The two monomers are colored green and purple;
secondary structure elements located at the dimer interface are
indicated in (b).
whereas the distance is >4 Å in molecule B. More signifi-
cantly, the rigid-body shift of residues 180–206 (see
above) between the two molecules places Lys185 much
closer to the C2 carboxylate (~4 Å) in molecule B, com-
pared to molecule A (> 6Å). This difference could explain
the apparent lower occupancy of QA in the active site of
molecule A.
A proposed mechanism for QAPRTase [5,25] involves the
reaction of QA with PRPP to produce pyrophosphate and
the hypothetical intermediate quinolinic acid mononu-
cleotide (QAMN), which decarboxylates via an ylide to
yield NAMN. It is not clear whether the decarboxylation
of QAMN is spontaneous or enzyme assisted. The evi-
dence for spontaneity of QAMN decarboxylation is based
on the elevated rates of spontaneous decarboxylation
observed for 1- and 3-substituted 2-pyridine carboxylic
acids [26] and related pyrimidines [27], but enzymatic
assistance of the decarboxylation seems quite plausible in
QAPRTase. The positively charged residues close to the
C2 and C3 carboxylate groups of QA are likely to stabilize
the ylide intermediate, by both inductive electron with-
drawal of negative charge from the pyridine ring via the
C3 carboxylate, and by possible direct stabilization of neg-
ative charge at C2 by interaction with Lys185 or Arg118. 
A negatively charged C2 substituent appears to be very
important for the binding of QA. NA has no negative
charge at position C2 and is not an inhibitor for E. coli and
S. typhimurium QAPRTase, whereas several compounds
with negative charges at this position have been shown to
be effective inhibitors [5,28]. From the crystal structure,
it is not clear exactly why such a strong preference is
exhibited for a negatively charged group at C2, as there
are more interactions with the C3 carboxylate than the C2
carboxylate. Arg118 and Lys185 could both move closer
to the C2 position, and indeed the flexibility observed in
the region (residues 180–206) could easily bring Lys185
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Figure 4
Stereo diagram of the active site of
QAPRTase showing bound QA. The QA
molecule and amino acid sidechains at the
active site are shown as a ball-and-stick
representation; residues at the active site are
labeled with the one letter code and their
number. Arg118 is marked with an
apostrophe to indicate that it is part of the
other subunit of the dimer. Nitrogen and
phosphorous atoms are shown in dark gray,
carbon atoms are in white and oxygen atoms
are in light gray.
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Figure 5
Electron density for ligands bound to QAPRTase. (a) Simulated
annealing ‘omit’ electron-density map of the active site of the
QAPRTase–QA complex, showing electron density (contoured at the
1s level) for the bound QA. (b) Difference fourier map, (|Fo|–|Fc|)fc, of
the active site of the QAPRTase–NAMN complex. The map was
calculated before addition of the NAMN coordinates to the model of
QAPRTase, and shows clear electron density for the bound NAMN
(final coordinates shown). The map is contoured at the 1.5s level.
(Figure generated using TOM [41].)
(a) (b)
to within hydrogen-bonding distance of the C2 carboxy-
late. Previous studies of multiply mutant strains of S.
typhimurium, defective in the de novo and salvage path-
ways of NAD biosynthesis, indicated that Lys185 might
play an important role in determining QAPRTase speci-
ficity. Mutant strains that could grow on NA rather than
QA were all shown to contain mutations of QAPRTase at
Lys185 (K Hughes, personal communication). However,
Lys185 is not conserved in two of the nine aligned
QAPRTase sequences (Fig. 7), casting some doubt on its
importance in conferring specificity, unless these two
sequences do not represent functional QAPRTases. (The
Rhodobacter capsulatus and Haemophilus influenzae DNA
sequences were identified as nadC genes on the basis of
their sequence similarity with other nadC genes and not
from functional data.)
Active site description: NAMN binding
Difference electron-density maps calculated with data
extending to 3.0Å resolution showed clear electron density
for the two NAMN molecules bound to QAPRTase in the
NAMN–QAPRTase complex (Fig. 5b); the two molecules
of the QAPRTase dimer appear to bind NAMN with equal
occupancy. The NA ring of NAMN occupies a very similar
position to that of QA, and the ribose phosphate groups
extend across the barrel towards b strands B9 and B10.
The nicotinate ring is in an anti conformation, pointing
away from the ribose phosphate group. Figure 8 shows the
interactions of NAMN with QAPRTase. The ribose
oxygens are within hydrogen-bonding distance of Lys185
Nz and Asp235 Od1 and are almost within hydrogen-
bonding distance to Glu214 Oε2 (3.65Å). The phosphate
group of NAMN makes interactions with the Nz atoms of
Lys153 and Lys284 and with mainchain nitrogens of
Asn260 and Gly280. A structural adjustment in the area of
residues 258–265 appears to accompany NAMN binding,
as the 5′-phosphate group displaces the Asn260 sidechain
from the position observed in the QA–QAPRTase
complex. In the QA–QAPRTase complex, the sidechain of
Asn260 partially occupies the phosphate-binding site and is
within hydrogen-bonding distance to Gly280. On binding
NAMN, the Asn260 sidechain moves away from the phos-
phate group (a shift of ~3Å in the Ca position, further for
the sidechain atoms) causing a 2–3Å shift of the entire
region of residues 260–265. Gly259 completely alters its
position, with its backbone NH moving towards the phos-
phate oxygens, resulting in a Ca displacement of 4Å. 
The conformation of residues 258–265 in the NAMN–
QAPRTase complex is moderately clear from the electron
density, whereas in the QA–QAPRTase complex there
appears to be some disorder, with poorly defined density
for residues Gly259, Asn260 and Val261.
Of the residues in the active-site area, most are strictly
conserved in the nine aligned QAPRTase sequences
(Fig. 7). Thr151, Arg152, Lys153, His174 and Arg175 are
conserved in all nine known QAPRTase sequences, con-
sistent with the interaction of Arg152 and Arg175 with the
bound QA, and the interaction of Lys153 with the phos-
phate of NAMN. Arg118, which appears to be involved in
intermolecular interactions with QA at the active site, is
conserved as an arginine residue in seven out of nine
sequences and is replaced by lysine in the remaining two
sequences.
In the ribose-binding site, Glu214 is conserved in all nine
aligned sequences and Asp235 is conserved in eight of nine,
changing to glutamatic acid in the R. capsulatus sequence.
These two acidic residues near the ribose oxygens are
strongly reminiscent of the two catalytically essential and
highly conserved acidic residues in the type I PRTases.
Several studies have shown that the transition states for
enzymatic phosphoribosyl transfer are oxycarbonium-like
[12,29], and a transition state structure with a high degree 
of oxycarbonium ion character has been deduced for the
reaction catalyzed by orotate PRTase [12]. By analogy to the
mechanisms proposed for orotate PRTase and HGPRTase
[9], Glu214 and Asp235 are likely to be involved in the
stabilization of a positively charged transition state in
QAPRTase. Activation of the ribose towards transition 
state formation might also include deprotonation at the
52 Structure 1997, Vol 5 No 1
Figure 6
The active site of QAPRTase, showing bound NAMN in stick
representation. The molecular surface of the protein is colored
according to electrostatic potential: red = negatively charged,
blue = positively charged. For the NAMN molecule, carbon atoms are
shown in yellow, phosphorous in purple, oxygen in red and nitrogen in
blue. (Figure generated using the program GRASP [50].)
2′-hydroxyl group and protonation of the leaving pyrophos-
phate. In QAPRTase, Glu214 is well positioned to under-
take d eprotonation of the 2′-hydroxyl. Potential proton
donating residues lining the putative pyrophosphate-bind-
ing site of QAPRTase include Lys153 and Lys185.
The phosphate-binding site provides the least conserved
region, in terms of sequence identity. As stated above,
Lys153 is conserved in all nine sequences, but Lys284
only occurs as a lysine residue in two; this residue is a
histidine in three of the aligned sequences and a gluta-
mine in two. In the two most divergent sequences, this
position is either ‘missing’ (R. capsulatus) or replaced by
tyrosine (H. influenzae). The contacts with mainchain
atoms (Asn260, Gly280) will be preserved despite side-
chain changes, but in fact both position 260 and 280 are
commonly glycine residues in QAPRTase sequences
(Fig. 7). In fact, the entire phosphate-binding ‘structure’
appears to be conserved amongst phosphate-binding
enzymes with a/b barrel structures (see below).
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Figure 7
Alignment of QAPRTase sequences showing
observed (obs) and predicted (phd pred;
predicted by PHD server [44,45]) secondary
structure. Helical (H) and b strand (E)
structures are indicated. For the predicted
secondary structure, only the prediction with
estimated accuracy of > 82 % is indicated.
Asterisks mark residues that are found at the
active site. Sequences are, from top to
bottom: Salmonella typhimurium (saltyqa);
Rhodobacter capsulatus (rhcapsqa);
Haemophilus influenzae (hemophilus);
Saccharomyces cerevisiae (yeastqa); human
(humanqa); Escherichia coli (ecoliqa);
Bacillus subtilis (bacsuqa); Rhodospirillum
rubrum (rhrubqa); and Mycobacterium leprae
(myclepqa).
1         10         20         29         37         47         57        
saltyqa  .PPRRYNPDD RRDALLERIN LD.IPAAVAQ ALREDLGG.. EVDAGNDITA QLLPADTQAH ATVITREDGV
rhcapsqa  .......... .........M FLIDDTALMA LIREDVPA.. ....GDLTTR SLGLAAEAGE LTMRARGAMT 
hemophilus  .......... .........M IYFSDKELDD LLLEDIYR.. ....GDLTTH ALSIENIPAK ILFKRKNAGV 
yeastqa  .......... ........MP VYEHLLPVNG AWRQDVTNWL SEDVPSFDFG GYVVGSDLKE ANLYCKQDGM 
humanqa  .......... ......MDAE GLALLLPP.V TLAALVDSWL REDCPGLNYA ALVSGAGPSQ AALWAKSPGV 
ecoliqa  MPPRRYNPDT RRDELLERIN LD.IPGAVAQ ALREDLGG.. TVDANNDITA KLLPENSRSH ATVITRENGV 
bacsuqa  .......... .....MNHLQ LKKL...LNH FFLEDIG... TGDLTS.QS. ..IFGEQSCE AEIVAKSEGI 
rhrubqa  ......MRPN HPVAALSPFA IDEA...VRR ALAEDLGR.. AGDITSTAT. ..IPAATRAH ARFVARQPGI 
myclepqa  .......... ....MLSDCE FDAARDTIRR ALHEDLRY.. GLDITTQAT. ..VPAGTVVT GSMVPREPGV 
obs                H HHHHHHHHHH HHHHHHHHHH HHHHH           HHHHH HH    EEEE EEEEE   EE
phd pred           H HHHHHHH         HHHHH HHHHHHHH                           EE       
67         77         83         93                    107        117       
saltyqa  FCGKRWVEEV FIQLAG.... DDVRLTWHVD DGDAIHANQ. .....TVFEL NGPARVLLTG ERTALNFVQT 
rhcapsqa  VACSEEAVRI LQLL...... .GAEAWIATA SGRQVEGGE. .....MLLFA RGQVEALLAG WKVAQNLIEW 
hemophilus  VAGVSVAEKL LKKL...... .DIQPHLYVK EGEWVESGA. .....LLISA EGMSEQLHQA WKVVQLVLEW 
yeastqa  LCGVPFAQEV FNQC...... .ELQVEWLFK EGSFLEPSKN DSGKIVVAKI TGPAKNILLA ERTALNILSR 
humanqa  LAGQPFFDAI FTQL...... .NCQVSWFLP EGSKLVPVAR ......VAEV RGPAHCLLLG ERVALNTLAR 
ecoliqa  FCGKRWVEEV FIQLAG.... DDVTIIWHVD DGDVINANQ. .....SLFEL EGPSRVLLTG ERTALNFVQT 
bacsuqa  FAGAAIIKEG FSLLD..... ENVQSILHKK DGDMLHKGE. .....VIAEL HGPAAALLSG ERVVLNLIQR 
rhrubqa  LAGLGCARSA FALLD..... DTVTFTTPLE DGAEIAAGQ. .....TVAEV AGAARTILAA ERTALNFLGH 
myclepqa  IAGVDV...A LLVLDEVFGV DGYRVLYRVE DGARLQSGQ. .....PLLTV QAAARGLLTA ERTMLNLVCH 
*
obs        EE HHHHHHH HHHHH         EEEEE     EEEE           EEEE EEEHHHHHHH HHHHHHHHHH
phd pred      HHHHHHH HHHH           EEEE                   EEEEE     HHHHHH HHHHHHHHHH 
127        137        145        155        165        175        185       
saltyqa  LSGVASEVRR YVGLLAGT.. QTQLLDTRKT LPGLRTALKY AVLCGGGANH RLGLTDAFLI KENH...IIA 
rhcapsqa  ASGLASSATA IVAAARAVNP AVTVACTRKS VPGTRALSLR AVTVGGATVH RTGLSDSVLL FAEHRA.FGG 
hemophilus  SCGVAQYTAE MIANAKSVNP TAVVACTRKS IPNTRKLATN AVLAAGGHIH RQGVSETLLV FTNHRNLLSD 
yeastqa  SSGIATASHK IISLARSTGY KGTIAGTRKT TPGLRRLEKY SMLVGGCDTH RYDLSSMVML KDNH...IWA 
humanqa  CSGIASAAAA AVEAARGAGW TGHVAGTRKT TPGFRLVEKY GLLVGGAASH RYDLGGLVML KDNH...VVP 
ecoliqa  LSGVASKVRH YVELLEGT.. NTQLLDTRKT LPGLRSALKY AVLCGGGANH RLGLSDAFLI KENH...IIA 
bacsuqa  LSGIATMTRE AVRCLDDE.. QIKICDTRKT TPGLRMLEKY AVRAGGGYNH RFGLYDGIMI KDNH...IAA 
rhrubqa  LSGIATRTRR FGDAIAHT.. RARLTCTRKT TPGLRGLEKY AVRCGGGSNH RFGLDDAVLI KDNH...IAV 
myclepqa  MSGIATVTVA WVDAVRGT.. KAKIRDTRKT LPGLRALQKY AVRVGGGVNH RLGLGDTALI KDNH...VAA 
***                      * *       *  *
obs        HHHHHHHHHH HHHHHH      EEEEEEE      HHHHHHH HHHHH  EEE E     EEEE  HHH   HHH 
phd pred   H   HHHHHH HHHHHH        E           HHHHHH                   EEE E         
192        202        211        221        230                   247       
saltyqa  SGSVRQAVEK AFWLHPD.VP VEVEVENLDE LDDALK.AGA DIIMLDNFN. ..TDQMREAV K...RVNGQA 
rhcapsqa  ADALAAQIAR LRASCPER.K VVVEVADVAE ALAAAQ.AGA EVLQLEKFPP EQVAAVVAGL GPDWRG.... 
hemophilus  PNDWTKIVDR LRQEAPEN.K ITLEADNYAQ FEQMYM.AEP DIIQLDKWLL EDVKKALDLL QSKQKD...I  
yeastqa  TGSITNAVKN ARAVCGFAVK IEVECLSEDE ATEAIE.AGA DVIMLDNFKG DGLKMCAQSL KNKWNGKKHF 
humanqa  PGGVEKAVRA ARQAADFALK VEVECSSLQE VVQAAE.AGA DLVLLDNFKP EELHPTATAL KAQFPS...V 
ecoliqa  SGSVRQAVEK ASWLHPD.AP VEVEVENLEE LDEALK.AGA DIIMLDNFE. ..TEQMREAV K...RTNGKA 
bacsuqa  CGSILEACKK ARQAAGHMVN IEVEIETEEQ LREAIA.AGA DVIMFDNCP. ..PDTVRHFA K...LTPANI 
rhrubqa  AGGVSAALSR ARAGVGHMVR IEIEVDTLEQ LAEVLAVGGA EVVLLDNMD. ..APTLTRAV D...MVAGRL 
myclepqa  VGSVVDALRA VRAAAPEL.P CEVEVDSLEQ LDAMLA.EEP ELILLDNFPV WQTQVAVQRR D...IRAPTV 
*                       *
obs        H  HHHHHHH HHHHH   EE EEEEEE HHH HHHHHH     EEEEEEE      HHHHHHHH H   H    E
phd pred      HHHHHHH HHHH       EEEE    HH HHHHHH      EEEEE        HHHHHHH          E
254        264        274        284        294
saltyqa  RLEVSGNVTA ETLREFAETG VDFISVGALT KHVRALDLSM RFC*...... ..... 
rhcapsqa  HVAAAGGITA ANAAP.MRRG RRFW...... .......... .......... ..... 
hemophilus  LLSVAGGVNK NNVSDYAKLG IRLFITSA.P YYVPPEDIKV VIEKI*.... ..... 
yeastqa  LLECSGGLNL DNLEEYLCDD IDIYSTSSIH QGTPVIDFSL KLAH*..... ..... 
humanqa  AVEASGGITL DNLPQFCGPH IDVISMGMLT QAVPALDFSL KLFAKEVAPV PKIH* 
ecoliqa  LLEVSGNVTD KTLREFAETG VDFISVGALT KHVQALDLSM RFR*...... ..... 
bacsuqa  KTEASGGITL ESLPAFKGTG VNYISLGFLT HSVKSLDI.. .......... ..... 
rhrubqa  VTEASGGVSL DTIAALAESG VDYISVGALT HSVTTLDIGL DIVVAPPKAE RA*..
myclepqa  LLESSGGLSL ENAAIYAGTG VDYLAVGALT HSVRILDIGL DL*....... ..... 
**                     **   *
obs        EEEEEEE    HHHHHHHH    EEEEE HHH HEEEEEEEE 
phd pred   EEEE       HHHHHHH     EEEE
The conserved phosphate-binding motif in a/b barrel
structures
The results from the alignment of similar 3D protein struc-
tures placed IGPS and flavocytochrome b2 as top scorers in
their degree of 3D similarity to the QAPRTase a/b barrel
(Table 1). Inspection of the aligned structures revealed
that, when the 3D structures are aligned using the
b strands of the a/b barrel, the phosphate moieties bound
to these two enzymes superimposed very well with the
5′-phosphate of NAMN bound to QAPRTase (Fig. 9). The
appearance of this phosphate-binding motif in at least eight
a/b barrel enzymes has been discussed [30]. In this group
of structures, the phosphate group is bound between the C-
terminal ends of the final two b strands of the a/b barrel
(i.e. between b strands 7 and 8 of conventional a/b barrel
structures and between b strands B9 and B10, the last two
b strands, of the QAPRTase a/b barrel). The sequence
conservation amongst the phosphate-binding motifs is
poor, but the structures overlay in quite a striking manner
(Fig. 9). There is almost no conservation of the basic
residues that coordinate the phosphate group; Lys153 (con-
served in QAPRTase) is equivalent to Lys55 in IGPS, but
has no exact counterpart in flavocytochrome b2. Not
surprisingly, Lys284, which is not conserved in QAPRTase,
is not observed in IGPS or the other phosphate-binding
a/b barrels. The short helix of residues 280–284 (helix A10)
in QAPRTase corresponds to the additional helix (a8′) 
in flavocytochrome b2, IGPS and TRPS(a).
QAPRTase and the other PRTases: a new fold for the
PRTase family
QAPRTase is the only known PRTase structure to
contain an a/b barrel fold. Orotate PRTase, HGPRTase
and glutamine-PRPP amidotransferase all have a similar
type I PRTase fold, consisting of five parallel b strands
surrounded by four a helices [7–9]. These PRTases
contain a conserved motif of 13 residues [7,9,31] that
serves to bind the ribose-phosphate moiety of the sub-
strate PRPP and is found at the center of the PRTase fold.
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Figure 8
Stereo diagram of the active site of
QAPRTase showing bound NAMN. NAMN is
shown in ball-and-stick representation; atoms
are labeled and colored as described in
Figure 4. 
H174
T151
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K284
K153
N260
D235
E214
H174
T151
R175
R152
K284
K153
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E214
Figure 9
Overlay of the phosphate-binding site regions of QAPRTase (in blue),
flavocytochrome b2 (in magenta) and indole-3-glycerol phosphate
synthase (in green). The bound NAMN is shown in stick form with atom
coloring as in Figure 6.
This motif does not appear in QAPRTase, being replaced
by residues from several different parts of the structure.
There are two acidic amino acid residues near the ribose
oxygens of the substrate, Glu214 and Asp235, but unlike
the type I PRTases, these residues are not adjacent in
sequence either to each other or to the phosphate-binding
site. The phosphate-binding site is a completely different
structure in QAPRTase, being composed of several differ-
ent entities rather than a continuous loop of five residues.
The phosphate-binding regions provided by QAPRTase
appear to form a conserved motif amongst a/b barrel
enzymes (see below).
Other PRTases of unknown structure show the 13-residue
motif (e.g. adenine PRTase and uracil PRTase), and will
most likely assume the type I PRTase fold of orotate
PRTase and HGPRTase. However, NAPRTase also lacks
the 13-residue ‘PRPP-binding’ motif [14], suggesting that
this enzyme may also lack the type I PRTase fold. It is
interesting that a (ba)8 structure has been predicted for
anthranilate PRTase [32], which contains an Asp-Glu-x-x-
x-x-Gly-x-Thr sequence, which is reminiscent of the con-
served motif of the type I PRTases, but is not clearly
conserved as in other type I PRTases.
In summary, the structure of QAPRTase is unusual in two
ways. Firstly, the structure is an irregular a/b barrel,
having only seven b strands, and only six surrounding
helices. However, the phosphate-binding motif has been
previously observed in a number of apparently unrelated
a/b barrel enzymes. This may suggest that QAPRTase is
evolutionarily related to these enzymes, possibly having
evolved from an ancestral (ba)8 structure with a phos-
phate-binding site. Secondly, QAPRTase is the first
PRTase to deviate from the five-b-stranded PRPP-
binding motif exhibited by HGPRTase, orotate PRTase,
and glutamine-PRPP amidotransferase. This observation
shows that members of the PRTase group of enzymes
have evolved convergently to perform similar functions
utilizing different protein architecture.
Biological implications
Quinolinic acid phosphoribosyltransferase (QAPRTase)
catalyzes the formation of nicotinic acid mononucleotide
(NAMN) from the substrates quinolinic acid (QA) and
phosphoribosyl pyrophosphate (PRPP). It is an essential
enzyme for the de novo synthesis of NAD. Quinolinic acid
(QA) is produced in most prokaryotes from the condensa-
tion of aspartic acid and dihydroxyacetone phosphate. In
animals the degradation of tryptophan produces QA,
which is also a known neurotoxin. QA has been shown to
be present at high levels in the central nervous systems of
patients with a broad spectrum of inflammatory neurolog-
ical diseases, including HIV-1 and meningitis [33,34]; it
has been proposed that the elevated QA levels may be
responsible for causing significant neurological damage 
in these patients. The high QA levels may arise from an
increase in indoleamine-2,3-dioxygenase activity, the first
step in the kynurenine tryptophan degradation pathway
[33]. QA is known to bind to N-methyl-D-aspartate recep-
tors, and may cause damage by overstimulation of these
receptors [35]. QAPRTase provides the only route for the
metabolism of QA.
In addition to its importance in the metabolism of QA and
its role in NAD biosynthesis, QAPRTase is of interest as
a member of the group of phosphoribosyltransferases
(PRTases) that utilize the substrate 5-phosphoribosyl-1-
pyrophosphate (PRPP). Structures of several PRTases
have now been published, and all show a common fold 
of five b strands surrounded by four a helices. The lack
of sequence similarity between QAPRTase and the other
PRTases was suggestive of a different three-dimensional
structure for this enzyme. 
The three-dimensional structure of QAPRTase from Sal-
monella typhimurium consists of two domains: an N-termi-
nal domain, containing a four-stranded b sheet and four
a helices in an antiparallel openface sandwich structure,
and a C-terminal domain which is a seven-stranded a/b
barrel. The different structure observed for QAPRTase
implies that it must have evolved from a different ances-
tor than other PRTases. The substrates bind to the a/b
barrel with the carboxylate groups of QA located in a
very cationic binding pocket, containing conserved argi-
nine, lysine and histidine residues. The 5′-phosphate
group of the product NAMN is located between the last
two b strands of the barrel, in a phosphate-binding site
that is extremely similar to those observed in other phos-
phate-binding a/b barrels, such as flavocytochrome b2
and indole-3-glycerol phosphate synthase.
Materials and methods
Materials
Buffers, reagent grade chemicals, and luria broth (LB) media were
obtained from Sigma. PEG-400 and MgCl2 for crystallizations were
obtained from Fluka. DEAE Toyo-Pearl ion exchange resin was from
Toso-Haas. Plasmid pSP73 and plasmid purification kits were obtained
from Promega, and restriction enzymes were supplied by New England
Biolabs. Polymerase chain reaction (PCR) reagents were purchased
from Perkin Elmer.
Preparation of QAPRTase
Plasmid pAD01 [12] was used as a template for PCR amplification of
the 900 bp nadC gene. The primers used (5′ GTTTTATCATAGC-
CGCCCTCGC 3′ and 5′ CATCGGCTGCAGAGGATCAGC 3′, base
changes underlined) introduced an NdeI site immediately 5′ of the start
codon, and a PstI site five bp 3′ of the stop codon. PCR products were
purified using a kit for this purpose (Promega), digested with NdeI and
PstI, gel purified, and ligated into pSP73 (Promega) previously cut with
the same enzymes. The resultant plasmid, designated pDOQA01, was
used to transform BL21(DE3) [36], yielding strain DOQA100. DNA
sequencing insured that no adventitious mutations had occurred in
nadC during PCR. For large scale (12 × 500 ml) growth, cells from a
freshly prepared and centrifugally washed overnight culture were used
to inoculate LB broth and the cultures allowed to grow with shaking
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until A550 nm = 0.8 was reached. At this time isopropyl-b-D-thiogalac-
topyranoside (IPTG) (0.4 mM final) was added, and growth allowed to
continue for 3 h. The cells were harvested by centrifugation, washed,
and resuspended in two volumes of buffer Q (0.1 M Tris, brought to
pH 8.0 with H3PO4, and containing 1 mM EDTA and 2.5 mM dithiothre-
itol (DTT). Cells were stored at –20 °C.
S. typhimurium QAPRTase was isolated from DOQA100 following the
procedure of Hughes et al. [13] with modifications and additional chro-
matographic steps. All steps were conducted at 0–4 °C, except for the
chromatography which was performed at room temperature. Following
thawing of cells, phenylmethyl sulfonyl fluoride was added to 1 mM
from a 0.3 M stock in isopropanol, and sonication was carried out for
three 1 min bursts at full power. After centrifugation at 12 000 rpm for
20 min, the supernatant was treated with 30 ul ml–1 of 10 % poly-
etheneimine, pH 8.0, and stirred for 15 min. The supernatant was cen-
trifuged, and the pellet dissolved in a minimal volume of buffer Q. The
solution was dialyzed overnight against three changes of buffer Q. Par-
ticulate matter was removed by centrifugation, and the solution applied
to a column (2.5 × 25 cm) of DEAE-Toyo-Pearl resin. The column was
eluted at a flow rate of 3 ml min–1 with a linear gradient of 0–0.5 M
Na2SO4 in buffer Q using a Pharmacia FPLC apparatus. Fractions
exhibiting QAPRTase activity emerged at 45 % of the gradient, and
were pooled and reprecipitated with 65 % saturation (NH4)2SO4. The
protein was redissolved in 0.1 M potassium phosphate buffer, pH 7.2
containing 1 mM EDTA and 2.5 mM DTT (buffer QKP), and dialyzed
against three changes of the same buffer overnight. The dialyzed
protein was then rechromatographed on DEAE-Toyo-Pearl resin, using
buffer QKP and a linear gradient of 0–0.5 M Na2SO4. Fractions con-
taining activity were pooled, precipitated with 65 % saturation
(NH4)2SO4, redissolved in 4 ml of buffer QKP containing 0.5 M
Na2SO4 and applied to a column (1.6 × 10 cm) of phenyl sepharose
(Pharmacia), equilibrated with the same buffer. The column was eluted
at a flow rate of 3 ml min–1 with a descending linear gradient of 0.5–0 M
Na2SO4. Fractions containing QAPRTase eluted at about 9.5 % of the
gradient and were pooled and brought to 65 % saturation (NH4)2SO4
and stored at 4 °C. The protein was homogeneous as judged by 15 %
SDS PAGE. The enzyme was assayed as described [13], and showed
a specific activity of 0.9 U mg–1.
Crystallization of QAPRTase
The initial crystallization conditions were found by a sparse matrix
screening method (Crystal Screen I, Hampton Research, CA). Crystals
of QAPRTase were prepared using the hanging-drop vapor diffusion
method. Recombinant S. typhimurium QAPRTase at 20–30 mgml–1 in
buffer (20mM Tris, pH8, 0.05% NaN3, 2mM DTT, 2mM QA) was mixed
1:1 with a precipitant solution of 25–30% PEG 400, 0.1M Hepes
pH7.1–7.5 and 0.2M MgCl2, and suspended over 1ml of the same
precipitant solution. Typically crystals appeared after a few days, and
grew to maximum dimensions of 0.5×0.2×0.2mm within one month.
The crystals diffract to a maximum resolution of 2.6Å. To produce crys-
tals with bound NAMN, apo-QAPRTase was crystallized using the same
precipitant solution described above (i.e. without QA in the hanging
drop). The apo-QAPRTase crystals were soaked for 24h in mother
liquor containing 2mM NAMN immediately prior to data collection.
Data collection and processing
X-ray data were collected at room temperature using a Siemens area
detector, with a Rigaku RU-200 rotating anode as the X-ray source.
Data were processed using the program XENGEN [37]. The unit cell
dimensions were determined to be a = b = 81.4 Å, c = 217.3 Å,
a = b = g = 90°. The space group was determined from pseudo-preces-
sion pictures [38] to be either P41212 or P43212. The asymmetric unit
contains a dimer of QAPRTase and 54 % solvent. The two molecules in
the asymmetric unit are related by an approximate twofold axis
(k = 179), which was calculated from the Hg and Ir atom positions,
then later recalculated after model building. Heavy-atom derivatives
were prepared by soaking QAPRT–QA co-crystals in a mother liquor
containing 28 % PEG 400, 0.1 M Hepes pH 7.1, 0.2 M MgCl2, and
heavy-atom concentrations in the range 1–3 mM. Derivatives that were
used in phase calculations were obtained using ethylmercuriphosphate
(EMP, 3 mM), mercuric acetate (1–2 mM), Sm(III)acetate (1.5 mM),
Nd(III)acetate (2 mM), K2IrCl6 (3 mM). The results of data collection and
phasing are summarized in Table 2.
Structure determination and refinement
Isomorphous difference Patterson maps were used to locate the
mercury atom positions in the EMP and mercuric acetate (MA) deriva-
tives. Trial protein phases were calculated from the mercury atom posi-
tions [38], then other derivatives were located using difference Fourier
maps. The space group was determined to be P41212 (as opposed to
its enantiomer P43212) by use of the anomalous scattering of the
iridium derivative [39]. The final figure of merit for the phase set calcu-
lated before solvent flattening was 0.62. Protein phases were calcu-
lated [38] to 3.0 Å, and solvent flattening and histogram matching were
employed to improve the phases [40]. The resulting electron-density
map was mostly interpretable, showing clear regions of continuous
electron density, to which a polyalanine chain was fitted using the
program TOM [41]. There were several breaks in the polyalanine chain
and very poor electron density for the N-terminal domain of each
monomer. One cycle of real-space averaging (RAVE [42]) of the elec-
tron density was undertaken, using a manually edited solvent mask
(MAMA [43]) and the non-crystallographic symmetry matrix calculated
from an incomplete model (2928 atoms, or 66 % of atoms). The result-
ing map allowed the remaining polypeptide chain in the N-terminal
region to be fitted. The alignment of the amino acid sequence onto the
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Table 2
QAPRTase structure determination and heavy-atom derivative data.
Data set Number Redundancy* Maximum Rsym† Rmerge‡ Phasing Completeness
of sites of data resolution (Å) power§ (%)
Native–QA – 5.3 2.8 0.12 – – 93
K2IrCl6 5 3.2 3.0 0.13 0.07 1.09 (0.81) 93
EMP†† 2 2.5 3.3 0.12 0.09 1.33 86
Hg acetate 2 2.8 3.0 0.11 0.08 1.48 (1.25) 88
Nd acetate 4 2.5 3.2 0.10 0.09 0.81 94
Sm acetate 4 2.3 3.5 0.11 0.10 0.76 94
*Number of observations/number of unique reflections. †Unweighted
absolute R factor on intensity: R = Σ | I – < I > | / ΣI, where I is the
observed intensity of a reflection, and < I > is the mean intensity of the
reflection. ‡Merging R factor (on F) with the native data set:
R = (Σ |FPH – FP |) / ΣFP, where FP and FPH are the native and
protein + heavy-atom structure factor, respectively. §Phasing power is
the ratio of the root mean square (rms) calculated heavy-atom structure
amplitude to the rms lack of closure. The values in parentheses are for
the anomalous diffraction data. ††EMP = ethylmercuriphosphate
derivative.
polyalanine chain was deduced by inspection of the electron density,
the observed heavy-atom binding sites (Table 3) and the predicted sec-
ondary structure [44,45]. As sidechains were fit into the electron
density, new electron-density maps were calculated using combined
model and heavy-atom phases.
Model building to phase combined electron-density maps resulted in
an initial model of 3774 protein atoms (558 of 592 residues) which
was refined by molecular dynamics and energy minimization (X-PLOR
[46]) with non-crystallographic restraints, using data to 2.8 Å. At all
stages of refinement, the Rfree was monitored for continued decreases
as more refinable parameters were introduced. At the resolution avail-
able, the observation : parameter ratio is approximately 1:1 when all
atoms and temperature factors are refined, leading to the possibility of
over fitting of the data. Monitoring the Rfree allowed us to judge that the
refinement was improving the model. The initial model had an R factor
of 45.3 %, which dropped to 26.3 % (Rfree = 40.7 %) after refinement.
Three further cycles of manual model building, using (3|Fo|–2|Fc|)fc
and (|Fo|–|Fc|)fc maps and energy minimization refinement, were
employed. Two further cycles of model building and refinement using
least squares methods [47] were performed, followed by one final
round of simulated annealing (‘slowcooling’ from 3000 K) and energy
minimization (using non-crystallographic restraints on mainchain atoms
only), followed by individual temperature-factor refinement. Difference
Fourier maps clearly revealed the location of bound QA, and this was
added to the model. Further cycles of model building and alternating
positional and B factor refinement in X-PLOR resulted in a final
R factor of 18.2 %, and Rfree of 27.4 % (Table 4). Non-crystallographic
restraints were removed in the final cycles of refinement. Both the con-
ventional R factor and Rfree continued to drop after the restraint was
released. A solvent mask correction (X-PLOR) was employed during
the final stages of refinement, using solvent parameters and refinement
protocol optimized by D Kostrewa (Hoffman LaRoche). Six solvent
atoms were added to the model at positions of well defined peaks of
electron density (at least 3s) in the (|Fo|–|Fc|)fc difference map, and
where hydrogen-bonding partners with the protein were available
within 3.5 Å.
The final model is a dimer (the subunits are labeled A and B; residues
of each subunit are labeled A8–A296 and B8–B296). Each subunit
of the dimer contains 289 of 296 residues (4444 total protein atoms
in dimer). There are also two molecules of QA and six solvent atoms.
One molecule of QA (molecule A) has been modeled at 50 % occu-
pancy, as the electron density in difference maps was weak and initial
modeling at 100 % occupancy resulted in unreasonably high temper-
ature factors for the molecule. The first seven residues of each
monomer are omitted from the model, as the electron density is
poorly defined. The rms deviations from ideal geometry are 0.010 Å
for bond lengths and 1.7 for bond angles. The average B factor for all
atoms is 45.9 Å2, rather higher than is typical. The average B factor
for mainchain atoms of the a/b barrel of molecule A is 40 Å2. The high
overall B factor probably reflects the poor quality of the data col-
lected at high resolution rather than any intrinsic disorder in the
crystal structure. There is one outlier in the Ramachandran plot,
Asn250 (and its NCS equivalent), which is located within a loop of
three residues between helix A8 and b strand B9. Simulated anneal-
ing omit maps calculated in this region confirmed the overall confor-
mation of this loop. The heavy-atom positions were found to fall next
to appropriate sidechains in the QAPRTase structure (Table 3). In
addition, there was good agreement of the observed secondary struc-
ture with the predicted secondary structure (Fig. 7). Simulated
annealing omit maps (X-PLOR) were made over all of the model, and
confirmed the structure.
For the structure of QAPRTase complexed with NAMN, the refined
QAPRTase coordinates without ligand or solvent were subjected to
rigid-body refinement, followed by simulated-annealing refinement
using X-PLOR (using data to 3.0 Å). Simulated annealing omit maps
and (3|Fo|–2|Fc|)fc maps were calculated, and the area around the
active site (in particular residues 250–270) were rebuilt. Alternating
energy minimization and group B factor refinement reduced the
R factor to 21.3% (Rfree = 33.4 %), and difference electron-density
maps clearly showed two molecules of NAMN bound to the
QAPRTase dimer (Fig. 5b). The ligands were added to the model, and
further model building at the active site, followed by energy minimiza-
tion and group B factor refinement reduced the R factor to 19.9 %
(Rfree = 32.4 %). The final statistics for the QAPRTase–NAMN structure
are summarized in Table 4.
Accession numbers
The coordinates of the QAPRTase–QA structure have been deposited
with the Brookhaven database, the accession code is 1QAP.
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Table 3
Heavy-atom binding sites in QAPRTase.
Heavy atom Protein ligand(s)††
Hg (EMP)* CysA168
Hg acetate* CysA168, CysA68
Pt1*† HisA56, CysB296
Pt2† MetA233, GluA214
Sm1, Nd1 GluA220, GluB220‡, GluA216
Sm2, Nd2 GluB220, GluB216
Sm3, Nd3 AspA223, AspB223‡
Sm4, Nd4 AspB512, AspA240
Ir1* In QA-binding site
Ir2* In phosphate-binding site
Ir3 B291 C = O (mainchain), LysA153,
GlnB125: in active-site area at dimer interface
*Sites were observed at equivalent positions in the NCS related
molecule. †The Pt derivative was obtained by soaking a QAPRTase
crystal overnight in mother liquor containing 4 mM K2PtCl4; sites were
located in difference Fourier maps but were not used for phasing. ††The
letter A or B refers to different monomers of the QAPRTase dimer
observed in the asymmetric unit of the crystal. ‡Indicates symmetry
related molecule. (Details of the derivatives are given in the text.)
Table 4
Summary of final statistics.
QAPRTase–QA QAPRTase–NAMN
Resolution (Å) 2.8 3.0
No. of crystals 2 1
Rsym (%)* 11.9 10.6
< I / I > 6.3 5.8
No. of unique reflections 17 451 13 925
Redundancy 5.3 2.9
Completeness (%) 92.7 90.7
R factor (%)† 18.6 19.9
Rfree (%)†† 27.4 32.3
Rms deviation bond lengths (Å) 0.01 0.015
Rms deviation bond angles (°) 1.7 2.0
*Rsym = unweighted absolute R factor on intensity: R = Σ | I – < I > | / ΣI,
where I is the observed intensity of a reflection, and < I > is the 
mean intensity of the reflection. †The R factor reported is for the data
with I / sI > 2. ††Rfree = R factor for a test set of reflections not used
during refinement (10 % of QAPRTase–QA data and 5 % of
QAPRTase–NAMN data).
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